Samuel Goldberg
Researcher in Psychedelic Science
Data updated
Papers
Trials
Research Footprint
Samuel Goldberg appears in 11 tracked papers (2020–2025), most studied alongside Psilocybin, DMT and MDMA, across Depressive Disorders, Anxiety Disorders and Safety & Risk Management.
Most-cited paper: The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis (230 citations).
Frequent co-authors: Otto Simonsson, Peter Hendricks and Wojciech Osika.
Publication Landscape
How the 11 papers Blossom tracks for Samuel Goldberg line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Samuel Goldberg's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 11 of 11 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Samuel Goldberg publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Samuel Goldberg publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Samuel B. Goldberg is a researcher working at the intersection of psychedelic science, contemplative practice, and population health. His work focuses on large‑scale and longitudinal analyses that probe how lifetime and recent use of classic psychedelics relate to engagement with meditation practices, health behaviours, and markers of physical and mental well‑being. Goldberg frequently applies epidemiological methods to survey datasets from the United States and the United Kingdom to identify associations and temporal patterns rather than conducting interventional trials.
Goldberg's contributions emphasise nuanced, data‑driven characterisations of who uses psychedelics and how such use correlates with subsequent or concurrent meditation practice and lifestyle factors. Key outputs include cross‑sectional and longitudinal studies on classic psychedelic use and current meditation practice, investigations of whether psychedelic experiences may benefit meditation, and analyses linking psychedelic exposure to health behaviour and physical health outcomes in population samples. His research supports a more integrative understanding of psychedelics within broader behavioural and mental‑health contexts and highlights directions for hypothesis generation and future experimental work.
Key Impact
Notable for population‑level and longitudinal research examining links between classic psychedelic use, meditation practice, and health‑related behaviours.
Collaboration Network
13 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Samuel Goldberg's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.